oxprenolol has been researched along with Retroperitoneal Fibrosis in 2 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Retroperitoneal Fibrosis: A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullimore, DW | 1 |
| McClusky, DR | 1 |
| Donaldson, RA | 1 |
| McGeown, MG | 1 |
2 other studies available for oxprenolol and Retroperitoneal Fibrosis
| Article | Year |
|---|---|
Retroperitoneal fibrosis associated with atenolol.
Topics: Atenolol; Blood Sedimentation; Humans; Oxprenolol; Practolol; Propanolamines; Retroperitoneal Fibros | 1980 |
Oxprenolol and retroperitoneal fibrosis.
Topics: Humans; Male; Middle Aged; Oxprenolol; Retroperitoneal Fibrosis | 1980 |